Pancragen Peptide

Pancreatic bioregulatory tetrapeptide (Lys-Glu-Asp-Trp). Researched for insulin regulation, beta-cell function, and metabolic pathway normalization.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUPANC-001
SequenceLys-Glu-Asp-Trp
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Pancragen (Lys-Glu-Asp-Trp)?

Pancreatic tetrapeptide that normalizes beta-cell gene expression and insulin secretion patterns. Research shows restored glucose-stimulated insulin secretion, improved islet cell survival, and normalized HbA1c in diabetic models.

Frequently Asked Questions

How does Pancragen affect insulin?

Pancragen normalizes beta-cell gene expression, restoring glucose-stimulated insulin secretion. It does not increase basal insulin (no hypoglycemia risk), only normalizes the glucose-responsive secretion pattern.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.